Hayward, California – July 4, 2024 – Endiatx, a trailblazing Silicon Valley medical technology company, proudly announces the latest breakthrough in gastrointestinal (GI) care with PillBot™. This revolutionary micro-robot is designed to navigate the human stomach, providing a cost-effective, non-invasive solution for GI diagnosis and treatment.Endiatx's mission is to reshape the future of medicine through innovative micro-robotics.
Introducing PillBot™
PillBot™, about the size of a vitamin pill, offers live video transmission as it motors through the water-filled stomach. After the patient drinks water and swallows PillBot™, a physician – who can it operate remotely – navigates PillBot™ via an internet-connected game controller to thoroughly scan the patient's stomach. This groundbreaking technology reduces the need for invasive procedures, lowers costs, and increases accessibility to GI diagnosis and treatment.
Clinical Trials and FDA Approval
Following the completion of clinical trials later this year, Endiatx anticipates FDA clearance for PillBot™ in 2025. The commercial launch in the US is expected in early 2026, with plans for international expansion, particularly in developing nations where access to GI medicine is limited. The ongoing clinical trials have shown promising results, demonstrating PillBot™'s efficacy and safety in real-world scenarios.
PillBot™ in Action
Endiatx’s innovative approach was showcased at the TED and Amazon MARS conferences, where Co-Founder Dr. Vivek Kumbhari demonstrated live navigation of PillBot™ throughout the stomach of Endiatx Chairman Dr. Alex Luebke. Dr. Kumbhari, Chairman of Gastroenterology and Hepatology at the Mayo Clinic, highlighted how PillBot™ will transform GI care. Four out of five upper endoscopies yield negative results – and show that there are no issues in the patient's stomach requiring medical treatment. So PillBot™ promises to save many patients from the discomfort of sedation and hospital visits, while providing insurers with a significantly lower bill. This innovative device will also optimize hospital resources for cases requiring further investigation after an initial PillBot™ screening.
The Future of GI Care with AI
Looking ahead, Endiatx envisions integrating AI to enhance PillBot™’s capabilities, enabling systematic screening and acute care diagnostics. This advancement could facilitate early detection of diseases like stomach cancer, which claims approximately 800,000 lives globally each year. The AI-enabled PillBot™ will autonomously scan the stomach, analyze data, and provide precise diagnostics, making GI care more efficient and accessible.
Expanding the Horizon
Endiatx's journey began in 2019, driven by a vision to revolutionize medical diagnostics through micro-robotics. Since then, the company has grown into a team of over 20 dedicated professionals and has raised $7 million in funding. The success of PillBot™ is a testament to the team's relentless pursuit of innovation and excellence. As Endiatx expands its product line, future devices will increasingly integrate Artificial Intelligence.
A New Era of Medical Robotics
Endiatx stands at the forefront of a new era in medical robotics. By leveraging cutting-edge technology and a commitment to improving patient outcomes, Endiatx is setting a new standard in GI care. The company’s innovative approach combines advanced engineering, AI, and medical expertise to create solutions that are not only effective but also patient-friendly. The PillBot™ exemplifies this commitment, offering a glimpse into the future of non-invasive medical diagnostics.
Join Us on Our Journey
Endiatx invites you to join us on our journey as we continue to innovate and push the boundaries of what is possible in medical technology. Stay updated on the latest developments by visiting our Press page and following us on LinkedIn, Instagram, X/Twitter, TikTok, and YouTube. Together, we can transform the future of medicine and make advanced healthcare accessible to everyone.
Media Contact: Please email press@endiatx.com or text/call +1 (781)-962-3057 for media inquiries.
Press Kit: Download our Press Kit here.
Follow Us: LinkedIn (opens in a new tab) | Instagram (opens in a new tab) | Twitter (opens in a new tab) | TikTok (opens in a new tab) | YouTube (opens in a new tab)
About Endiatx
Founded in 2019, Endiatx is a pioneering medical technology company based in Silicon Valley. Our mission is to revolutionize medical diagnostics through the development of advanced micro-robotics. Our flagship product, PillBot™, is designed to navigate the human stomach, providing a cost-effective, non-invasive solution for GI diagnosis and treatment. By integrating AI and innovative engineering, Endiatx is committed to making advanced healthcare accessible to all.
Endiatx: Revolutionizing GI Care, One PillBot™ at a Time.